Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · March 07, 2023

Considering Cost-Effectiveness of Cardiovascular and Kidney Complications of Type 2 Diabetes With Widespread Use of SGLT2i and GLP-1



Additional Info

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
Diabetologia 2023 Apr 01;66(4)642-656, JI Morton, C Marquina, JE Shaw, D Liew, KR Polkinghorne, Z Ademi, DJ Magliano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading